NDC 60793-601-10 Bicillin Cr
Penicillin G Benzathine And Penicillin G Procaine Injection, Suspension Intramuscular
Package Information
The table below has all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.
| NDC Package Code | 60793-601-10 |
| Package Description | 10 SYRINGE in 1 PACKAGE / 2 mL in 1 SYRINGE (60793-601-02) |
| Product Code | 60793-601 |
| Proprietary Name What is the Proprietary Name? The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. |
Bicillin Cr |
| Non-Proprietary Name What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. |
Penicillin G Benzathine And Penicillin G Procaine |
| Substance Name What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted. |
Penicillin G Benzathine; Penicillin G Procaine |
| Usage Information Product Usage Information The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs. |
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.This drug is indicated in the treatment of moderately severe infections due to penicillin-G-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. Therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response.Bicillin C-R is indicated in the treatment of the following in adults and pediatric patients:Moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci.NOTE: Streptococci in Groups A, C, G, H, L, and M are very sensitive to penicillin G. Other groups, including Group D (enterococci), are resistant. Penicillin G sodium or potassium is recommended for streptococcal infections with bacteremia.Moderately severe pneumonia and otitis media due to susceptible Streptococcus pneumoniae.NOTE: Severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin G sodium or potassium during the acute stage.When high, sustained serum levels are required, penicillin G sodium or potassium, either IM or IV, should be used. This drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta. |
| 11-Digit NDC Billing Format NDC Format for Billing For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration. |
60793060110 |
| Billing Unit | ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume. |
| NDC to RxNorm Crosswalk | |
| Product Type What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing. |
Human Prescription Drug |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Dosage Form | Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. |
| Administration Route(s) |
|
| Active Ingredient(s) | |
| Pharmacologic Class(es) | |
| Sample Package Sample Package? This field Indicates whether this package is a sample packaging or not. |
No |
| Marketing Category What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
NDA - A product marketed under an approved New Drug Application. |
| FDA Application Number What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
NDA050138 |
| Start Marketing Date What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product. |
05-18-1953 |
| Listing Expiration Date What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler. |
12-31-2023 |
| Exclude Flag What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I". |
N |
| NDC Code Structure |
|
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 60793-601-10 HCPCS crosswalk information with package details and bill units information.
| NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
|---|---|---|---|---|---|---|---|
| 60793060110 | J0558 | Peng benzathine/procaine inj | 100,000 UNITS | 2 | 10 | 12 | 120 |
* Please review the disclaimer below.
Frequently Asked Questions
What is NDC 60793-601-10?
The NDC Packaged Code 60793-601-10 is assigned to a package of 10 syringe in 1 package / 2 ml in 1 syringe (60793-601-02) of Bicillin Cr, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is injection, suspension and is administered via intramuscular form.
Is NDC 60793-601 included in the NDC Directory?
Yes, Bicillin Cr with product code 60793-601 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on May 18, 1953 and its listing in the NDC Directory is set to expire on December 31, 2023 if the product is not updated or renewed by the manufacturer.
What is the NDC billing unit for package 60793-601-10?
The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.
What is the 11-digit format for NDC 60793-601-10?
The 11-digit format is 60793060110. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.
This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:
| 10-Digit Package Format | 10-Digit Original Package Code | 11-Digit Package Format | 11-Digit Conversion Package Code |
|---|---|---|---|
| 5-3-2 | 60793-601-10 | 5-4-2 | 60793-0601-10 |